nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—Central nervous system disorder—Furosemide—dilated cardiomyopathy	0.0498	0.106	CcSEcCtD
Tranexamic Acid—Diuresis—Furosemide—dilated cardiomyopathy	0.0322	0.0689	CcSEcCtD
Tranexamic Acid—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.0312	0.0667	CcSEcCtD
Tranexamic Acid—PLG—Platelet degranulation—TTN—dilated cardiomyopathy	0.0248	0.0467	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.0237	0.0445	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.0215	0.0405	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—PSEN1—dilated cardiomyopathy	0.0215	0.0404	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.0205	0.0386	CbGpPWpGaD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—ITGB1—dilated cardiomyopathy	0.0191	0.036	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—VCL—dilated cardiomyopathy	0.0183	0.0344	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—PSEN1—dilated cardiomyopathy	0.0175	0.033	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.0174	0.0328	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ITGB1—dilated cardiomyopathy	0.0154	0.0289	CbGpPWpGaD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—RAC1—dilated cardiomyopathy	0.0154	0.0289	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—AGTR1—dilated cardiomyopathy	0.0146	0.0275	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—ITGB1—dilated cardiomyopathy	0.0134	0.0252	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—RAC1—dilated cardiomyopathy	0.0124	0.0232	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.0121	0.0227	CbGpPWpGaD
Tranexamic Acid—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.012	0.0257	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—RPS6KB1—dilated cardiomyopathy	0.0119	0.0224	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.011	0.0207	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—LAMA4—dilated cardiomyopathy	0.0109	0.0205	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—RAC1—dilated cardiomyopathy	0.0108	0.0202	CbGpPWpGaD
Tranexamic Acid—Renal failure—Spironolactone—dilated cardiomyopathy	0.0101	0.0216	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—SOD2—dilated cardiomyopathy	0.00984	0.0185	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00955	0.0179	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—GPX1—dilated cardiomyopathy	0.00939	0.0176	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—RAC1—dilated cardiomyopathy	0.00832	0.0156	CbGpPWpGaD
Tranexamic Acid—Polyuria—Furosemide—dilated cardiomyopathy	0.00826	0.0176	CcSEcCtD
Tranexamic Acid—Swelling—Furosemide—dilated cardiomyopathy	0.00822	0.0176	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00812	0.0153	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—CD36—dilated cardiomyopathy	0.00784	0.0147	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00782	0.0147	CbGpPWpGaD
Tranexamic Acid—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00772	0.0165	CcSEcCtD
Tranexamic Acid—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00759	0.0162	CcSEcCtD
Tranexamic Acid—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.0075	0.016	CcSEcCtD
Tranexamic Acid—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.0075	0.016	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00749	0.016	CcSEcCtD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.00747	0.014	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00746	0.014	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00745	0.0159	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.00735	0.0138	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.00724	0.0136	CbGpPWpGaD
Tranexamic Acid—Malaise—Spironolactone—dilated cardiomyopathy	0.00724	0.0155	CcSEcCtD
Tranexamic Acid—Discomfort—Spironolactone—dilated cardiomyopathy	0.00675	0.0144	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00667	0.0143	CcSEcCtD
Tranexamic Acid—PLG—amb2 Integrin signaling—TNF—dilated cardiomyopathy	0.00666	0.0125	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00655	0.014	CcSEcCtD
Tranexamic Acid—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00653	0.014	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.00589	0.0111	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.00589	0.0111	CbGpPWpGaD
Tranexamic Acid—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00574	0.0123	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—TTN—dilated cardiomyopathy	0.00568	0.0107	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00566	0.0121	CcSEcCtD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—dilated cardiomyopathy	0.00563	0.0106	CbGpPWpGaD
Tranexamic Acid—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00562	0.012	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00555	0.0119	CcSEcCtD
Tranexamic Acid—Renal failure—Furosemide—dilated cardiomyopathy	0.00549	0.0117	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0054	0.0115	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00537	0.0101	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ACTN2—dilated cardiomyopathy	0.00492	0.00925	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00492	0.00924	CbGpPWpGaD
Tranexamic Acid—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.0049	0.0105	CcSEcCtD
Tranexamic Acid—Visual impairment—Furosemide—dilated cardiomyopathy	0.00483	0.0103	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00483	0.0103	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00478	0.00899	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00478	0.00899	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Furosemide—dilated cardiomyopathy	0.00469	0.01	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—TNF—dilated cardiomyopathy	0.00466	0.00876	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.00459	0.00862	CbGpPWpGaD
Tranexamic Acid—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00458	0.00979	CcSEcCtD
Tranexamic Acid—Angiopathy—Furosemide—dilated cardiomyopathy	0.00455	0.00973	CcSEcCtD
Tranexamic Acid—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00453	0.00968	CcSEcCtD
Tranexamic Acid—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00448	0.00958	CcSEcCtD
Tranexamic Acid—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00448	0.00958	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00444	0.00835	CbGpPWpGaD
Tranexamic Acid—Dizziness—Spironolactone—dilated cardiomyopathy	0.00433	0.00926	CcSEcCtD
Tranexamic Acid—Muscle spasms—Furosemide—dilated cardiomyopathy	0.0042	0.00897	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—VCL—dilated cardiomyopathy	0.00419	0.00787	CbGpPWpGaD
Tranexamic Acid—Vomiting—Spironolactone—dilated cardiomyopathy	0.00417	0.0089	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00413	0.00883	CcSEcCtD
Tranexamic Acid—Renal failure—Lisinopril—dilated cardiomyopathy	0.00412	0.00881	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00411	0.00878	CcSEcCtD
Tranexamic Acid—Headache—Spironolactone—dilated cardiomyopathy	0.0041	0.00877	CcSEcCtD
Tranexamic Acid—Anaemia—Furosemide—dilated cardiomyopathy	0.00404	0.00863	CcSEcCtD
Tranexamic Acid—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00393	0.00841	CcSEcCtD
Tranexamic Acid—Nausea—Spironolactone—dilated cardiomyopathy	0.00389	0.00832	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—TNF—dilated cardiomyopathy	0.00373	0.00701	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00356	0.00762	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.00354	0.00665	CbGpPWpGaD
Tranexamic Acid—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.0035	0.00747	CcSEcCtD
Tranexamic Acid—Flushing—Lisinopril—dilated cardiomyopathy	0.00349	0.00747	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00348	0.00654	CbGpPWpGaD
Tranexamic Acid—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00342	0.0073	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00339	0.00725	CcSEcCtD
Tranexamic Acid—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00336	0.00719	CcSEcCtD
Tranexamic Acid—Hypotension—Furosemide—dilated cardiomyopathy	0.00333	0.00712	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.00328	0.00616	CbGpPWpGaD
Tranexamic Acid—Back pain—Lisinopril—dilated cardiomyopathy	0.00317	0.00677	CcSEcCtD
Tranexamic Acid—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00315	0.00673	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00308	0.00658	CcSEcCtD
Tranexamic Acid—Fatigue—Furosemide—dilated cardiomyopathy	0.00307	0.00657	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00304	0.0065	CcSEcCtD
Tranexamic Acid—Anaemia—Lisinopril—dilated cardiomyopathy	0.00303	0.00647	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00296	0.00557	CbGpPWpGaD
Tranexamic Acid—Malaise—Lisinopril—dilated cardiomyopathy	0.00295	0.00631	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00294	0.00628	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00291	0.00623	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00288	0.00615	CcSEcCtD
Tranexamic Acid—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00282	0.00602	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00281	0.00527	CbGpPWpGaD
Tranexamic Acid—Chest pain—Lisinopril—dilated cardiomyopathy	0.00279	0.00596	CcSEcCtD
Tranexamic Acid—Myalgia—Lisinopril—dilated cardiomyopathy	0.00279	0.00596	CcSEcCtD
Tranexamic Acid—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00279	0.00596	CcSEcCtD
Tranexamic Acid—Discomfort—Lisinopril—dilated cardiomyopathy	0.00276	0.00589	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00273	0.00513	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00273	0.00513	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00267	0.00572	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00263	0.00561	CcSEcCtD
Tranexamic Acid—Asthenia—Furosemide—dilated cardiomyopathy	0.00256	0.00547	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—RAF1—dilated cardiomyopathy	0.00254	0.00477	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00254	0.00477	CbGpPWpGaD
Tranexamic Acid—Hypotension—Lisinopril—dilated cardiomyopathy	0.0025	0.00534	CcSEcCtD
Tranexamic Acid—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00244	0.00521	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00244	0.00521	CcSEcCtD
Tranexamic Acid—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00238	0.0051	CcSEcCtD
Tranexamic Acid—Dizziness—Furosemide—dilated cardiomyopathy	0.00236	0.00504	CcSEcCtD
Tranexamic Acid—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00235	0.00503	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.00232	0.00436	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00231	0.00493	CcSEcCtD
Tranexamic Acid—Fatigue—Lisinopril—dilated cardiomyopathy	0.00231	0.00493	CcSEcCtD
Tranexamic Acid—Vomiting—Furosemide—dilated cardiomyopathy	0.00227	0.00484	CcSEcCtD
Tranexamic Acid—Headache—Furosemide—dilated cardiomyopathy	0.00223	0.00477	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.0022	0.00471	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00219	0.00467	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.00217	0.00408	CbGpPWpGaD
Tranexamic Acid—Nausea—Furosemide—dilated cardiomyopathy	0.00212	0.00452	CcSEcCtD
Tranexamic Acid—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00211	0.00452	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—ITGB1—dilated cardiomyopathy	0.0021	0.00395	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—ACE—dilated cardiomyopathy	0.002	0.00376	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00197	0.00421	CcSEcCtD
Tranexamic Acid—Asthenia—Lisinopril—dilated cardiomyopathy	0.00192	0.0041	CcSEcCtD
Tranexamic Acid—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00183	0.00391	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—CD36—dilated cardiomyopathy	0.00179	0.00337	CbGpPWpGaD
Tranexamic Acid—Dizziness—Lisinopril—dilated cardiomyopathy	0.00177	0.00378	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—EGFR—dilated cardiomyopathy	0.00174	0.00327	CbGpPWpGaD
Tranexamic Acid—Vomiting—Lisinopril—dilated cardiomyopathy	0.0017	0.00363	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—RAC1—dilated cardiomyopathy	0.00169	0.00317	CbGpPWpGaD
Tranexamic Acid—Headache—Lisinopril—dilated cardiomyopathy	0.00168	0.00358	CcSEcCtD
Tranexamic Acid—Nausea—Lisinopril—dilated cardiomyopathy	0.00159	0.00339	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—AGT—dilated cardiomyopathy	0.00127	0.00239	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00114	0.00214	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—RAF1—dilated cardiomyopathy	0.00112	0.00211	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00101	0.0019	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00101	0.0019	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00097	0.00182	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00094	0.00177	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00091	0.00171	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000778	0.00146	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000738	0.00139	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000634	0.00119	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000573	0.00108	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000553	0.00104	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AGT—dilated cardiomyopathy	0.000547	0.00103	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00038	0.000714	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00026	0.000489	CbGpPWpGaD
